A Study to Evaluate Efalizumab Compared With Cyclosporine As an Immunosuppressant Regimen in De Novo Renal Transplantation
Clinical trial NCT00729768 · WITHDRAWN
Trial details
- NCT number
- NCT00729768
- Sponsor
- Genentech, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.